Amir Satvat


amir.satvat.wg11@wharton.upenn.edu Boston College, Carroll School of Management, Chestnut Hill, MA B.S., Cum Laude, Finance, 2004 New York University, Wagner School of Public Service, New York, NY M.P.A., Health Policy and Management, 2009 University of Pennsylvania, School of Engin - eering and Applied Sciences, Philadelphia, PA M.B. Candidate, Biotechnology, 2011


A business development or consulting role in life sciences.


University of Pennsylvania, Wharton School, Philadelphia, PA Research Assistant, Summer 2010 Co-authored a book with Professor Lawton Burns involving five case studies on successful organizational change in health care institutions. Performed primary research on companies in the hospital, physician group, consolidated health system and insurance sectors.


Mozergy Biofuels, Ann Arbor, MI Chief Financial Officer, 2008


Created Biodiesel startup venture pro- ducing nonfood-based renewable fuel while aiding sustainable development in Africa. Won first place and received $20,000 in the WalMart Better Living Business Plan Challenge 2008.


Goldman, Sachs & Company, New York, NY


Analyst, Healthcare Investment Banking Group, 2004-2006


Sole analyst for UnitedHealth’s $8.5B acquisition of PacifiCare. Created new financial security for hedging health care-related pension deficits, present- ed to General Motors. Worked on biotech, pharmaceutical, life sciences and managed care deals. Executed sell-side and buy-side mergers and IPO/secondary equity and straight/hybrid debt offerings.


Joseph H. Scattergood


joseph.scattergood.wg11@wharton.upenn.edu Brown University, Providence, RI A.B., Psychology & Hispanic Studies, 2004


Jay M. Schomaker


jay.schomaker.wg11@wharton.upenn.edu Otterbein University, Westerville, OH B.A., Cum Laude, Economics and Finance, 2005


An opportunity to leverage my pricing and reimbursement expertise into a strategic marketing position at an innovative health care company.


Pfizer Inc, New York, NY Marketing Summer Associate, Summer 2010


Leveraged novel market research insights to drive development and approval of pilot Hispanic market creative for multiple brands, ensuring alignment to general market strategies and regional media needs. Developed frameworks and processes to successfully bring multicultural pieces to market to be used for all brands going forward.


IMS Health Consulting, Pricing & Market Access Practice, New York, NY Consultant, 2007-2009 Analyst, 2006-2007


Developed positioning strategies, customer segmentations, and value propositions for top biopharmaceuti- cal companies across multiple geographies, products, and categories. Designed research and conducted interviews with stakeholders across the health care continuum. Project management responsibilities included overseeing junior staff, directing client relationships, developing deliverables, and presenting results to senior executives.


Memorial Sloan-Kettering Cancer Center, New York, NY


Research Study Assistant, 2004-2006 Managed clinical chemotherapy and immunotherapy trials, resulting in co- authorship of 3 published articles and a presentation at ASCO. Coordinated communication with biopharmaceuti- cal sponsors and the Institutional Review Board around data monitoring and adverse event reporting.


An opportunity to leverage my strategy and transaction experience in a health care-focused corporate development or private equity environment.


Catalent Pharma Solutions, Somerset, NJ MBA Intern, Corporate Development and Strategy, Summer 2010


Collaborated with members of the executive team to identify, prioritize, and implement strategic growth initiatives. Established operating metrics to track progress and serve as leading indicators to future revenue.


CareFusion, San Diego, CA Consultant (part-time), Corporate Development, 2009 Established standardized valuation model and executive presentation template for newly-formed medical equipment spin-off of Cardinal Health.


Cardinal Health, Dublin, OH Manager, Strategy and Corporate Development, 2008-2009 Senior Analyst, 2007-2008


Evaluated organic and inorganic growth opportunities; conducted preliminary due diligence on business strategy and industry landscape; led financial valuation and analysis; developed and defended business cases; supported members of senior management on all aspects of the transaction. Co-managed a team of 3 analysts and was selected by Finance Council as 1 of 20 to participate in Emerging Leaders Program.


Financial Development Program, 2005-2007


Completed first-year rotation in Financial Planning and Analysis. Interviewed and was selected for second-year rotation in Corporate Strategy.


25


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40